Table 2 Exposure information for visit 1 (n = 216) and visit 2 (n = 145) for the participants in the metabolomic-wide association study
From: Impact of prenatal phthalate exposure on newborn metabolome and infant neurodevelopment
Metabolite (ng/ml) | Visit 1 (8–14 weeks) n = 216 | Visit 2 (24–30 weeks) n = 145 | Fourth national report on human exposure to environmental chemicals (2015–2016) | |||
---|---|---|---|---|---|---|
Median (IQR) | GM | Median (IQR) | GM | Age \({\ge }\)20 GM | Non-Hispanic black GM | |
Monoethyl phthalate (MEP) | 98 (44, 233) | 103 | 81 (34, 180) | 83.1 | 35.9 | 54.9 |
Mono-n-butyl phthalate (MBP) | 11 (5, 20) | 9.8 | 10 (5, 26) | 9.2 | 9.36 | 10.9 |
Monoisobutyl phthalate (MiBP) | 10 (4, 19) | 8.8 | 8 (3, 16) | 7.5 | 8.03 | 9.29 |
Monobenzyl phthalate (MBzP) | 6 (2, 13) | 5.7 | 5 (2, 11) | 4.9 | 3.87 | 5.57 |
Mono-2-ethylhexyl phthalate (MEHP) | 1.7 (0.6, 4.6) | 1.7 | 2.4 (0.7, 5.0) | 1.8 | # | 1.27 |
Mono-2-ethyl-5-oxohexyl phthalate (MEOHP)* | 3.1 (1.7, 6.5) | 3.3 | 3.7 (1.5, 7.1) | 3.1 | 3.36 | 3.66 |
Mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP)* | 5 (3, 11) | 5.3 | 5 (2, 9) | 4.2 | 5.40 | 5.96 |
Mono-2-ethly-5-carboxypentyl phthalate (MECPP)* | 7 (4, 13) | 8.1 | 6 (4, 11) | 7.1 | 8.28 | 8.51 |
Sum of Di-2-ethylhexyl phthalate metabolites (\({{{\boldsymbol{\Sigma }}}}\)DEHP) | 0.06 (0.03, 0.11) | 0.07 | 0.06 (0.03, 0.11) | 0.06 | - | - |